Safecor Health Recalls Atorvastatin Calcium 40mg Tablets Due to CGMP Deviations
Safecor Health is voluntarily recalling 119 bottles of Atorvastatin Calcium 40mg tablets in Massachusetts and New York due to Current Good Manufacturing Practice (CGMP) deviations.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and is a voluntary, firm-initiated action due to CGMP deviations without reported illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Safecor Health, LLC is voluntarily recalling 119 bottles of Atorvastatin Calcium 40mg tablets, 30-count bottles, prescription only. The product is identified by NDC 60505258009, Lot # A18661, and an expiration date of 10/31/2017.
The recall was initiated because of Current Good Manufacturing Practice (CGMP) deviations. The affected product was distributed in Massachusetts and New York. The recall was initiated on July 7, 2016, and was terminated on July 12, 2017.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for guidance on obtaining a replacement. The recall was initiated by the firm and classified as Class II by the FDA.
The recalled product
- Product
- Atorvastatin Calcium 40mg Tablet, 30-count bottles, Rx only, Pk By Safecor Health Woburn, MA 01801, NDC 60505258009
- Manufacturer
- Safecor Health, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 119
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # A18661
- Exp. 10/31/2017
Distribution
Part of a larger recall action
This product is one of 6 recalled by Safecor Health, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Safecor Health, LLC
See all →- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateAtorvastatin Calcium Tablets Recalled for Manufacturing Quality Violations
FDA (Drugs) · 2023-05-03
- HighAtorvastatin Calcium tablets recalled due to manufacturing practice deviations
FDA (Drugs) · 2023-03-08
- HighAtorvastatin Calcium 80 mg tablets recalled for manufacturing quality deviations
FDA (Drugs) · 2023-03-08
- ModeratePrescription Drug Recall: Atorvastatin Calcium Tablets for Manufacturing Deviations
FDA (Drugs) · 2023-03-08
- ModerateApotex Recalls Atorvastatin Calcium Tablets Due to Foreign Tablet Presence
FDA (Drugs) · 2019-11-06
- ModerateAtorvastatin Calcium Tablets 20 mg Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-04-12